Rabbit IgG antibodies against phospholipase A2 from Crotalus durissus terrificus neutralize the lethal activity of the venom

Medicina

Volumn 66, Issue 6, 2006, Pages 512-516

  Rodriguez, Juan P ^a   De Marzi, Mauricio ^b   Maruñak, Silvana ^a   Malchiodi, Emilio L ^b   Leiva, Laura C ^a   Acosta, Ofelia ^a  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antibodies IgG; Crotalus durissus terrificus; Neutralization; Phospholipase A2

Indexed keywords

CROTOXIN; FREUND ADJUVANT; IMMUNOGLOBULIN G; PHOSPHOLIPASE A2; SNAKE VENOM; SNAKE VENOM ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENVENOMATION; ENZYME ISOLATION; GEL FILTRATION CHROMATOGRAPHY; INCUBATION TIME; INOCULATION; LETHALITY; MALE; MORTALITY; MOUSE; MUSCLE DISEASE; NEUROTOXICITY; NONHUMAN; RABBIT; SNAKE; TREATMENT OUTCOME;

ANIMALS; ANTIBODY SPECIFICITY; ANTIVENINS; BUFFERS; CROTALUS; CROTOXIN; HEMOLYSIS; IMMUNOGLOBULIN G; MALE; MICE; NEUROMUSCULAR BLOCKADE; NEUTRALIZATION TESTS; PHOSPHOLIPASES A; RABBITS;

EID: 33846438994     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Slotta KH, Fraenkel-Conrat HL. Schlangengifte, III: Mitteilung Reiningung und Krystallization des Klapperschangengiftes. Ber Dich Chem Ges 1938; 71: 1076-81.
2. Brazil OV. Pharmacology of crystaline crotoxin. II. Neuromuscular blocking action. Mem Inst Butantan 1966; 33: 981-92.
3. Azevedo-Marques MM, Cupo P, Coimbra TM, Hering SE, Rossi MA, Laure CJ. Myonecrosis, myoglobinuria and acute renal failure induced by South-American rattlesnake (Crotalus durissus terrificus) envenomation in Brazil. Toxicon 1982; 23: 631-6.
4. Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. In: Bücherl W, Buckley EE (eds). Venomous Animals and their Venoms, vol. 2. New York: Academia Press, 1971, p 345-84.
5. Landucci, EC, Condino-Neto A, Perez AC, et al. Crotoxin induces aggregation of human washed platelets. Toxicon 1994; 32: 217-26.
6. Hendon RA, Fraenkel-Conrat H. Biological roles of the two components of crotoxin. Proc. Natl Acad Sci USA 1971; 68: 1560-3.
7. 2 and the crotoxin complex. Toxicon 1976; 14: 221-33.
8. Bon C, Changeux JP, Jeng TW, Fraenkel-Conrat H. Postsynaptic effects of crotoxin and of its isolated subunits. Eur J Biochem 1979; 99: 471-81.
9. Faure G, Harvey AL, Thomson E, Saliou B, Radvani F, Bon C. Comparison of crotoxin isoforms reveals that stability of the complex plays a major role in its pharmacological action. Eur J Biochem 1993; 214: 491-6.
10. Richardson WH, Tanen DA, Tong TC, et al. Crotalidae polyvalent immune Fab (Ovine) antivenom is effective in the neutralization of South American Viperidae venoms in a murine model. Ann Emerg Med 2005; 45: 595-602.
11. Otero R, Núñez V, Barona J, Díaz A, Saldarriaga, M. Características bioquímicas y capacidad neutralizante de cuatro antivenenos polivalentes frente a los efectos farmacológicos y enzimáticos de Bothrops asper y Porthidium nasutum de Antioquia y Chocó. Iatreia 2002; 15: 1-10.
12. Chipaux JP, Goyffon M. Venoms, antivenoms and inmunotherapy. Toxicon 1998; 36: 823-46.
13. De Roodt A, García S, Gómez C, et al. Antitoxinas y antivenenos para uso terapéutico. Acta Toxicol Argent 2004; 12: 29-41
14. Ouchterlony O. Antigen-antibody reactions in gels. Acta Path Microbiol Scand 1949; 26: 507-15.
15. Theakston RDG, Warrell DA, Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003; 41: 541-57.
16. Gutierrez JM, Avila C, Rojas E, Cerdas L. An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica. Toxicon 1988; 26: 411-3.
17. Habermann E, Rübsamen K. Biochemical and Pharmacological analysis of the so-called crotoxin. In: De Vries, A, Kochva, E. (eds). Toxin of Animal and Plants Origin, vol I. London: Gordon and Breach, 1971, p 333-41
18. Omori-Satoh T, Lang J, Breithhaupt H, Habermann E. Partial aminoacid sequence of the basic Crotalus phospholipase A. Toxicon 1975; 13: 69-71,
19. León G, Lomonte B, Gutiérrez JM. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon 2005; 45: 123-8.